(Q34064184)

30 July 2017

1 reference

title

Liposome targeting to tumors using vitamin and growth factor receptors (English)

1 reference

30 July 2017

Drummond DC

1

1 reference

30 July 2017

Hong K

2

1 reference

30 July 2017

Park JW

3

1 reference

30 July 2017

Benz CC

4

1 reference

30 July 2017

Kirpotin DB

5

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

published in

Vitamins and Hormones

1 reference

30 July 2017

volume

60

1 reference

30 July 2017

page(s)

285-332

1 reference

A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Liposomal drug formulations. Rationale for development and what we can expect for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Diffusion of univalent ions across the lamellae of swollen phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Toward selection of internalizing antibodies from phage libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

EGF receptor expression, regulation, and function in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins Dependence on cholesterol content and phospholipid composition

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Synthesis and characterization of N-acylated, pH-sensitive 'caged' aminophospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

In vitro selection of RNA molecules that bind specific ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Phase I study of liposomal vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Insulin and alpha 2-macroglobulin-methylamine undergo endocytosis by different mechanisms in rat adipocytes: I. Comparison of cell surface events

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folate-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Riboflavin-mediated delivery of a macromolecule into cultured human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

A high-affinity folate binding protein in proximal tubule cells of human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

The high-affinity folate binding protein in normal and malignant mammary gland tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

A Phase I multicenter study of E1A gene therapy for patients with metastatic breast cancer and epithelial ovarian cancer that overexpresses HER-2/neu or epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Preparation of EGF labeled liposomes and their uptake by hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines--a trial for less immunogenic chimeric toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Measurement of endosome pH following folate receptor-mediated endocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Site-directed mutagenesis of the yeast V-ATPase B subunit (Vma2p)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Synthesis and biological activity of ribose-5'-carbamate derivatives of vitamin B(12)

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

A vacuolar-type proton ATPase mediates acidification of plasmalemmal vesicles during potocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Monoclonal antibody-based therapies for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Catecholamine uptake and concentration by liposomes maintaining pH gradients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Stability of HER-2/neu expression over time and at multiple metastatic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Anti-HER2 immunoliposomes for targeted therapy of human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Immunoliposomes for cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Receptor-mediated endocytosis of hormones in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Endocytosis of GPI-linked membrane folate receptor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Targeting of liposomes to cells bearing nerve growth factor receptors mediated by biotinylated nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Protein kinase C activators inhibit receptor-mediated potocytosis by preventing internalization of caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Endocytosis of growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Autocrine growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Overexpression of folate binding protein in ovarian cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Epidermal growth factor receptor expression as a prognostic indicator in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Radioiodination of cyanocobalamin conjugates containing hydrophilic linkers: preparation of a radioiodinated cyanocobalamin monomer and two dimers, and assessment of their binding with transcobalamin II

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Liposome-anchored vascular endothelial growth factor aptamers

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Direct measurement of a tethered ligand-receptor interaction potential

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Folic acid transport in organ-cultured mucosa of human intestine. Evidence for distinct carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

PHYSICAL STRUCTURE AND BEHAVIOR OF LIPIDS AND LIPID ENZYMES.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

Therapeutic application of anti-growth factor receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2800%2960022-5

7 January 2021

10.1016/S0083-6729(00)60022-5

Identifiers

DOI

1 reference

30 July 2017

1 reference